Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viking Therapeutics, Inc. | 12,650 | reported | 02 Jan 2026 | tx 35+331,422−137,572 |
| CUBIST PHARMACEUTICALS INC | 1,104 | reported | 12 Jun 2013 | tx 42+180,151−101,347 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 3,150 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 20,400 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 18,800 | 0.00 USD | deriv |
| 25 Oct 2024 | SALE | Viking Therapeutics, Inc. | 16,000 | 79.50 USD | |
| 25 Oct 2024 | EXERCISE | Viking Therapeutics, Inc. | 16,000 | 4.48 USD | |
| 25 Oct 2024 | EXERCISE | Viking Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 20 Sept 2024 | EXERCISE | Viking Therapeutics, Inc. | 10,300 | 1.19 USD | |
| 20 Sept 2024 | SALE | Viking Therapeutics, Inc. | 10,300 | 69.50 USD | |
| 20 Sept 2024 | EXERCISE | Viking Therapeutics, Inc. | 10,300 | 0.00 USD | deriv |
| 21 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 5,700 | 1.19 USD | |
| 21 Aug 2024 | SALE | Viking Therapeutics, Inc. | 5,700 | 69.72 USD | |
| 21 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 5,700 | 0.00 USD | deriv |
| 19 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 16,000 | 3.33 USD | |
| 19 Aug 2024 | SALE | Viking Therapeutics, Inc. | 1,501 | 64.88 USD | |
| 19 Aug 2024 | SALE | Viking Therapeutics, Inc. | 2,388 | 64.10 USD | |
| 19 Aug 2024 | SALE | Viking Therapeutics, Inc. | 2,055 | 63.15 USD | |
| 19 Aug 2024 | SALE | Viking Therapeutics, Inc. | 4,509 | 61.86 USD | |
| 19 Aug 2024 | SALE | Viking Therapeutics, Inc. | 3,047 | 61.13 USD | |
| 19 Aug 2024 | SALE | Viking Therapeutics, Inc. | 2,500 | 60.01 USD | |
| 19 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 14 Aug 2024 | SALE | Viking Therapeutics, Inc. | 20,626 | 57.52 USD | |
| 14 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 20,786 | 8.00 USD | |
| 14 Aug 2024 | SALE | Viking Therapeutics, Inc. | 160 | 58.37 USD | |
| 14 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 20,786 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Viking Therapeutics, Inc. | 32,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 31 May 2018.